DB17879InvestigationalOrganism Based Therapies
Bacteroides thetaiotaomicron is a live biotherapeutic. Developed by 4D Pharma, Thetanix, an oral formulation comprising lyophilized Bacteroides thetaiotaomicron, is being investigated for the treatment of Crohn’s disease.
- Mechanism
- Curator reviewed
Pharmacologically active on Nuclear factor NF-kappa-B
Resolves to
Compound
What you can answer from here — as of July 08, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which companies are running trials of Bacteroides thetaiotaomicron, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account